When auditing Learningrx, what level of professional judgment and skepticism should be exercised?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
In performing an audit in accordance with generally accepted auditing standards, we:
- Exercise professional judgment and maintain professional skepticism throughout the audit.
- Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of LearningRx Franchise Corporation's internal control. Accordingly, no such opinion is expressed.
- Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.
- Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about LearningRx Franchise Corporation's ability to continue as a going concern for a reasonable period of time.
Source: Item 23 — RECEIPT (FDD pages 54–209)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, auditors are expected to exercise professional judgment and maintain professional skepticism throughout the audit. This means the auditors must critically assess the information provided by Learningrx and its management, and not simply accept it at face value. They need to be alert to potential misstatements, whether due to fraud or error, and design their audit procedures to address those risks. This approach is consistent with generally accepted auditing standards.
The auditors' responsibilities include identifying and assessing the risks of material misstatement in Learningrx's financial statements. They will examine evidence regarding the amounts and disclosures in the financial statements on a test basis. The auditors also need to understand Learningrx's internal controls to design appropriate audit procedures, though they won't express an opinion on the effectiveness of those controls.
Furthermore, the auditors will evaluate the appropriateness of Learningrx's accounting policies and the reasonableness of significant accounting estimates made by its management. They must also determine if there are any conditions or events that raise substantial doubt about Learningrx's ability to continue as a going concern. These evaluations are crucial for providing reasonable assurance that the financial statements are free from material misstatement.
The auditors are also required to communicate with those charged with governance within Learningrx regarding the planned scope and timing of the audit, any significant audit findings, and any internal control-related matters identified during the audit. This communication ensures transparency and allows for timely resolution of any issues that may arise. This rigorous process aims to provide stakeholders with reliable and accurate financial information about Learningrx.